These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 16542005)

  • 1. Elevated PrPC expression predisposes to increased HSV-1 pathogenicity.
    Thackray AM; Bujdoso R
    Antivir Chem Chemother; 2006; 17(1):41-52. PubMed ID: 16542005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PrP(c) expression influences the establishment of herpes simplex virus type 1 latency.
    Thackray AM; Bujdoso R
    J Virol; 2002 Mar; 76(5):2498-509. PubMed ID: 11836428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
    Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
    Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
    Ellison AR; Yang L; Voytek C; Margolis TP
    Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting herpes simplex virus reactivation from the explanted mouse brain.
    Yao HW; Ling P; Chen SH; Tung YY; Chen SH
    Virology; 2012 Nov; 433(1):116-23. PubMed ID: 22884293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts.
    Margolis TP; Imai Y; Yang L; Vallas V; Krause PR
    J Virol; 2007 Feb; 81(4):1872-8. PubMed ID: 17151134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggravation of ischemic brain injury by prion protein deficiency: role of ERK-1/-2 and STAT-1.
    Spudich A; Frigg R; Kilic E; Kilic U; Oesch B; Raeber A; Bassetti CL; Hermann DM
    Neurobiol Dis; 2005 Nov; 20(2):442-9. PubMed ID: 15893468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus type 1 latency-associated transcript gene promotes neuronal survival.
    Thompson RL; Sawtell NM
    J Virol; 2001 Jul; 75(14):6660-75. PubMed ID: 11413333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal control of herpes simplex virus latency.
    Tenser RB; Edris WA; Hay KA
    Virology; 1993 Aug; 195(2):337-47. PubMed ID: 8393231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression from the herpes simplex virus type 1 latency-associated promoter in the murine central nervous system.
    Smith C; Lachmann RH; Efstathiou S
    J Gen Virol; 2000 Mar; 81(Pt 3):649-62. PubMed ID: 10675402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transneuronal spread phenotype of herpes simplex virus type 1 infection of the mouse hind footpad.
    Engel JP; Madigan TC; Peterson GM
    J Virol; 1997 Mar; 71(3):2425-35. PubMed ID: 9032380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune control of herpes simplex virus during latency.
    Khanna KM; Lepisto AJ; Decman V; Hendricks RL
    Curr Opin Immunol; 2004 Aug; 16(4):463-9. PubMed ID: 15245740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune control of HSV-1 latency.
    Decman V; Freeman ML; Kinchington PR; Hendricks RL
    Viral Immunol; 2005; 18(3):466-73. PubMed ID: 16212525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice.
    Mott KR; Perng GC; Osorio Y; Kousoulas KG; Ghiasi H
    J Virol; 2007 Dec; 81(23):12962-72. PubMed ID: 17898051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The latency-associated gene of herpes simplex virus type 1 (HSV-1) interferes with superinfection by HSV-1.
    Mador N; Panet A; Steiner I
    J Neurovirol; 2002 Dec; 8 Suppl 2():97-102. PubMed ID: 12491159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral-oesophageal inoculation of mice with herpes simplex virus type 1 causes latent infection of the vagal sensory ganglia (nodose ganglia).
    Gesser RM; Valyi-Nagy T; Altschuler SM; Fraser NW
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2379-86. PubMed ID: 8077936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue-specific splicing of the herpes simplex virus type 1 latency-associated transcript (LAT) intron in LAT transgenic mice.
    Gussow AM; Giordani NV; Tran RK; Imai Y; Kwiatkowski DL; Rall GF; Margolis TP; Bloom DC
    J Virol; 2006 Oct; 80(19):9414-23. PubMed ID: 16973547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transgenic ICP4 promoter is activated in Schwann cells in trigeminal ganglia of mice latently infected with herpes simplex virus type 1.
    Taus NS; Mitchell WJ
    J Virol; 2001 Nov; 75(21):10401-8. PubMed ID: 11581408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological features of herpes simplex virus type 1 latency in mice according to experimental conditions and type of neurones.
    Cavallero S; Huot N; Francelle L; Lomonte P; Naas T; Labetoulle M
    Invest Ophthalmol Vis Sci; 2014 Oct; 55(12):7761-74. PubMed ID: 25324284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.